Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

LG Life Sciences patents new FFA4 receptor agonists

May 28, 2014

Animal model of hypertriglyceridemia developed in zebrafish

May 28, 2014

Taliglucerase alfa approved in Australia for Gaucher's disease

May 27, 2014

Shionogi patents novel AMPK activators for diabetes

May 27, 2014

Taisho Pharmaceutical launches Lusefi in Japan

May 26, 2014

Forxiga launched in Japan for the treatment of type 2 diabetes

May 26, 2014

Extended recombinant PTH treatment demonstrates good efficacy for hypoparathyroidism

May 26, 2014

Empagliflozin approved in E.U.

May 23, 2014

Empagliflozin evaluated in patients with diabetes and hypertension in phase III trials

May 23, 2014

Terumo BCT and Kaneka collaborate on therapeutic apheresis and columns for LDL reduction

May 22, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026